Skip to content
DataLookout
Menu

WINDOWNCT06477991

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.

StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Clinical complete response rate with negative MRD
Timeframe: 2023/10/30-2026/10/30

Arms and interventions

Drugs: Tireilizumab(PD-1 inhibitor)

Sites

1 site in 1 country

  • Yunnan Cancer HospitalKunming, Yunnan, China